期刊文献+

早期妊娠妇女血浆中血小板活化因子含量和血小板活化因子-乙酰水解酶活性的变化及意义 被引量:1

下载PDF
导出
摘要 目的:探讨早期妊娠妇女血浆中血小板活化因子(platelet-activating factor,PAF)的含量、血小板活化因子-乙酰水解酶(PAF-acetyl-hydrolase,PAF-AH)的活性变化及意义。方法:通过病史询问、妇科检查及B超确定早孕。采用生物法检测120例早期妊娠妇女和20例正常非孕妇女血浆中的PAF含量,同时采用酶水解底物显色法测定血浆中的PAF-AH活性,放射免疫法检测血清中的hCG-β。结果:早期妊娠妇女血浆中PAF含量为(12.5±4.3)ng/mL,正常非孕妇女为(6.7±2.8)ng/mL,两组比较差异有显著性(P<0.01);早期妊娠妇女血浆中PAF-AH活性为(17±1.1)nmol/(min·mL),正常非孕妇女为(32±1.8)nmol/(min·mL),两组比较差异有显著性(P<0.01)。结论:早期妊娠妇女血浆中PAF含量和PAF-AH活性的变化在妊娠的发生和发展中起着较为重要的作用。
出处 《实用医学杂志》 CAS 北大核心 2009年第21期3607-3608,共2页 The Journal of Practical Medicine
基金 遵义医学院附属医院院基金资助项目[编号:(2006)06号]
  • 相关文献

参考文献10

  • 1O'Neill C. The role of PAF in embryo physiology [J]. Hum Reprod Update, 2005,11(3) :215-228.
  • 2姚新生,孙万邦,王燕妮,李官成.酶联免疫吸附夹心法检测血小板活化因子[J].中华检验医学杂志,2000,23(1):38-39. 被引量:12
  • 3Frostegard J, Wramsby M L, Wu R. Antibodies against plateletactiviating factor and platelet-activating factor-like lipids are raised in women with primary recurrent abortion [J]. Am J Obstet Gynecol, 2003,189(2) :568-573.
  • 4黄蓉华,邱超珍,袁明生.联合动态测定血绒毛膜促性腺激素及孕酮预测早孕结局[J].国际医药卫生导报,2007,13(13):56-57. 被引量:6
  • 5Tiemann U, Tomek W, Schneider F. Platelet-activating factor (PAF) -like activity,localization of PAF receptor (PAF-R) and PAF-acetylbydrolase (PAF-AH) activity in bovine endometrium at different stages of the estrous cycle and early pregnancy [J]. Prostaglandins Other Lipid Mediat.2001,65 ( 2-3 ) : 125-141.
  • 6Roudebush W E, Massey J B, Kort H I. Exposure of preimplantation embryos to platelet-activating factor increases birth rate [J]. J Assist Reprod Genet, 2004, 21 (8) : 297-300.
  • 7Roudebush W E, Wininger J D, Jones A E. Embryonic plateletactiviating factor : an indicator of embryo viability [ J ]. Hum Reprod, 2002, 17(5) : 1306-1310.
  • 8姚新生,孙万邦,龙本栋.心力衰竭患者血小板活化因子及其受体表达的变化[J].临床心血管病杂志,2002,18(12):631-632. 被引量:3
  • 9姚新生,孙万邦,谢政军.应激性溃疡中血小板活化因子的变化及银杏叶提取物的防治作用的实验研究[J].中华消化杂志,2002,22(5):319-320. 被引量:15
  • 10Purnell E T, Warner C M, Kort H I. Influence of the preimplantation embryo development (Ped) gene on embryonic platelet-aetivatingfaetor (PAF) levels [J]. AssitReprodGenet, 2006,23 (6) : 269-273.

二级参考文献16

  • 1邓亚丽,李晓玲.血清孕酮测定对异位妊娠诊断与监测的价值[J].中国实用妇科与产科杂志,2005,21(2):106-106. 被引量:33
  • 2邱少东,曾碧丹,曾杰.彩色多普勒超声检测异位妊娠患者卵巢黄体血流动力学变化的临床价值[J].中国实用妇科与产科杂志,2006,22(9):700-701. 被引量:8
  • 3Hanahan D J, Weintraub S T. Platelet activating factor isolation identification and assay. Methods Biochem Anal. 1985,31:195-219.
  • 4Serebruany V L, Gurbel P A, Murugesan S R, et al. Depressed plasma platelet-activating factor acetylhydro lase in patients presenting with acute myocardial infarction. Cardiology, 1998,90(2) :127-130.
  • 5Montrucchi G, Lupia E, Battaglia E. Platelet-activating factor enhances vascular endothelial growth factor-induced endothelial cell motility and neoangiogenesis in murine matrigel model. Arterioscler Thromb Vasc Biol, 2000 , 20(1): 80-88.
  • 6Goudevenos J, Tselepis A D, Vini M P, et al. Plateletassociated and secreted PAF-acetylhydrolase activity in patients with stable angina: Sequential changes of the enzyme activity after angioplasty. Eur J Clin Invest, 2001,31(1) :15-23.
  • 7Yamada Y, Yoshida H, Ichihara S, et al. Correlations between plasma platelet-activating factor acetylhydrolase (PAF-AH)activity and PAF-AH genotype, age, and atherosclerosis in a Japanese population. Atherosclerosis, 2000,150(1) :209-216.
  • 8Morgan E N, Yun W, Kovacich J C, et al. Platelet-ac tivating factor acetylhydrolase prevents myocardial ischemia-reperfusion injury. Circulation, 1999, 100 ( 19Suppl): Ⅱ 365-368.
  • 9Vasange M, Rolfsen W, Bohlin L A. Subphonoglyco lipid from the fern polypodium decumanum and its effect on platelet activating-factor receptor in human neutrophils. J Pharm Pharmacol, 1997,49(5) :562-566.
  • 10巴德年,当代免疫学技术与应用,1998年,309-326,439-469页

共引文献32

同被引文献6

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部